CORRECTED-BRIEF-Cangene cancels IGIV development program

Tue Jul 10, 2012 5:20pm EDT

(Fixes typo in headline)

July 10 (Reuters) - July 10 (Reuters) - Cangene Corp : * Cancels IGIV development program * Says has cancelled its product development program for immune globulin intravenous

FILED UNDER: